Kai Wang Selected Research

Kai Wang Research Topics

Disease

641	Neoplasms (Cancer) 07/2024 - 06/2002
146	Inflammation (Inflammations) 05/2024 - 03/2002
103	Infections 05/2024 - 04/2006
94	Hepatocellular Carcinoma (Hepatoma) 07/2024 - 04/2008
83	Neoplasm Metastasis (Metastasis) 05/2024 - 12/2008
63	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 09/2010
63	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2008
57	Chronic Hepatitis B 01/2024 - 06/2004
53	Lung Neoplasms (Lung Cancer) 04/2024 - 08/2011
51	Fibrosis (Cirrhosis) 01/2024 - 10/2006
43	Carcinoma (Carcinomatosis) 03/2024 - 01/2008
42	Body Weight (Weight, Body) 03/2024 - 01/2011
41	Carcinogenesis 07/2024 - 10/2009
39	Hypoxia (Hypoxemia) 04/2024 - 11/2008
39	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2004
37	Glioma (Gliomas) 12/2023 - 01/2013
36	Adenocarcinoma of Lung 04/2024 - 09/2010
35	Wounds and Injuries (Trauma) 01/2024 - 07/2010
33	Obesity 05/2024 - 10/2010
33	COVID-19 10/2023 - 01/2020
32	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 09/2015
31	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 05/2011
28	Type 2 Diabetes Mellitus (MODY) 02/2024 - 11/2014
27	Reperfusion Injury 03/2024 - 07/2002
27	Stroke (Strokes) 01/2024 - 01/2013
26	Ischemic Stroke 08/2023 - 08/2016
25	Atherosclerosis 05/2024 - 07/2003
25	Liver Failure 12/2023 - 01/2011
23	Thrombosis (Thrombus) 04/2024 - 02/2003
23	Pneumonia (Pneumonitis) 04/2024 - 11/2007
23	Myocardial Infarction 03/2024 - 02/2003
23	Pain (Aches) 02/2024 - 01/2013
23	Ischemia 01/2024 - 07/2002
23	Cognitive Dysfunction 01/2024 - 10/2013
23	Hypertension (High Blood Pressure) 01/2024 - 05/2014
22	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 07/2012
22	Stomach Neoplasms (Stomach Cancer) 05/2024 - 12/2008
21	Esophageal Squamous Cell Carcinoma 10/2019 - 10/2009
20	Disease Progression 02/2024 - 12/2015
20	Adenocarcinoma 02/2024 - 11/2008
20	Nasopharyngeal Carcinoma 12/2022 - 02/2013
20	Necrosis 06/2022 - 01/2010
19	Schizophrenia (Dementia Praecox) 06/2024 - 12/2007
19	Insulin Resistance 05/2024 - 01/2009
19	Melanoma (Melanoma, Malignant) 11/2023 - 01/2016
19	Hemorrhage 08/2023 - 10/2012
17	Colitis 04/2024 - 05/2010
17	Non-alcoholic Fatty Liver Disease 02/2023 - 06/2011
17	Hyperplasia 01/2023 - 10/2002
16	Parkinson Disease (Parkinson's Disease) 04/2024 - 04/2012
16	Liver Diseases (Liver Disease) 02/2024 - 09/2003
15	Heart Failure 04/2024 - 12/2004
15	Liver Neoplasms (Liver Cancer) 02/2024 - 04/2008
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 01/2013

Drug/Important Bio-Agent (IBA)

212	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2002
161	Biomarkers (Surrogate Marker)IBA 05/2024 - 06/2002
78	MicroRNAs (MicroRNA)IBA 02/2024 - 03/2009
77	Messenger RNA (mRNA)IBA 07/2024 - 08/2005
65	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 09/2003
56	RNA (Ribonucleic Acid)IBA 06/2024 - 01/2008
56	CytokinesIBA 05/2024 - 03/2002
56	Long Noncoding RNAIBA 05/2024 - 12/2013
52	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2009
48	LipidsIBA 03/2024 - 01/2011
44	EnzymesIBA 07/2024 - 09/2010
35	AntioxidantsIBA 04/2024 - 03/2007
31	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2008
30	ErbB Receptors (EGF Receptor)IBA 01/2024 - 12/2009
29	Therapeutic UsesIBA 04/2024 - 11/2009
28	Interleukin-6 (Interleukin 6)IBA 04/2024 - 01/2006
26	LigandsIBA 12/2023 - 07/2002
25	Phosphotransferases (Kinase)IBA 02/2024 - 08/2012
22	VaccinesIBA 02/2024 - 11/2005
22	Indicators and Reagents (Reagents)IBA 01/2024 - 03/2002
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 03/2002
21	Antiviral Agents (Antivirals)IBA 05/2024 - 08/2014
21	Transcription Factors (Transcription Factor)IBA 01/2024 - 12/2008
21	CollagenIBA 10/2023 - 01/2011
20	Insulin (Novolin)FDA Link 10/2023 - 10/2016
19	Peptides (Polypeptides)IBA 03/2024 - 04/2005
19	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 04/2016
18	HydrogelsIBA 04/2024 - 11/2015
18	Small Interfering RNA (siRNA)IBA 02/2024 - 12/2008
18	Oxygen (Dioxygen)IBA 01/2024 - 08/2014
18	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2014
17	LipopolysaccharidesIBA 04/2024 - 01/2016
17	Immune Checkpoint InhibitorsIBA 02/2024 - 03/2016
17	CateninsIBA 12/2023 - 05/2014
16	CholesterolIBA 05/2024 - 02/2015
16	Triglycerides (Triacylglycerol)IBA 02/2024 - 01/2013
16	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2018
16	C-Reactive ProteinIBA 01/2023 - 06/2005
15	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2013

Therapy/Procedure

313	Therapeutics 05/2024 - 02/2003
88	Drug Therapy (Chemotherapy) 02/2024 - 12/2010
71	Radiotherapy 05/2024 - 11/2008
54	Immunotherapy 05/2024 - 03/2016
31	Liver Transplantation 02/2024 - 03/2012
20	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 03/2008
18	Aftercare (After-Treatment) 03/2023 - 11/2009